title: Single-tablet, once-daily treatment regimens for HIV.
authors.affiliation: School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, State University of New York, Buffalo, NY, USA.
authors.forename: Joshua R
authors.initials: JR
authors.lastname: Sawyer
authors.affiliation: School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, State University of New York, Buffalo, NY, USA.
authors.forename: Qing
authors.initials: Q
authors.lastname: Ma
authors.affiliation: Infectious Disease Division, School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, USA; Positive Health Clinic, Allegheny General Hospital, Pittsburgh, PA 15212, USA. Electronic address: cbhsiao@gmail.com.
authors.forename: Chiu-Bin
authors.initials: CB
authors.lastname: Hsiao
mesh_terms: D000225:Adenine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives; D000480:Alkynes; D019380:Anti-HIV Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D048588:Benzoxazines / Q000008:administration & dosage / Q000009:adverse effects; D002219:Carbamates / Q000008:administration & dosage / Q000009:adverse effects; D000069547:Cobicistat; D003521:Cyclopropanes; D065692:Cytochrome P-450 CYP3A Inhibitors; D003841:Deoxycytidine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives; D004338:Drug Combinations; D000068679:Emtricitabine; D015658:HIV Infections / Q000188:drug therapy*; D019428:HIV Integrase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects; D054303:HIV Reverse Transcriptase / Q000037:antagonists & inhibitors; D006801:Humans; D009570:Nitriles / Q000008:administration & dosage / Q000009:adverse effects; D063065:Organophosphonates / Q000008:administration & dosage / Q000009:adverse effects; D011743:Pyrimidines / Q000008:administration & dosage / Q000009:adverse effects; D015363:Quinolones / Q000008:administration & dosage / Q000009:adverse effects; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects; D000068696:Rilpivirine; D000068698:Tenofovir; D013844:Thiazoles / Q000008:administration & dosage / Q000009:adverse effects
chemical_list: D000480:Alkynes; D019380:Anti-HIV Agents; D048588:Benzoxazines; D002219:Carbamates; D003521:Cyclopropanes; D065692:Cytochrome P-450 CYP3A Inhibitors; D004338:Drug Combinations; D019428:HIV Integrase Inhibitors; D009570:Nitriles; D063065:Organophosphonates; D011743:Pyrimidines; D015363:Quinolones; D018894:Reverse Transcriptase Inhibitors; D013844:Thiazoles; D003841:Deoxycytidine; C509700:elvitegravir; D000068698:Tenofovir; D054303:HIV Reverse Transcriptase; D000068696:Rilpivirine; D000068679:Emtricitabine; D000225:Adenine; C098320:efavirenz; D000069547:Cobicistat